BIOMAT Database Logo BIOMAT Database Logo

[A clofibric acid derivative with hypolipemic and platelet antiaggregant action]. 1988

G Dănilă, and M Nechifor, and M Filip, and I Păduraru, and C Ifrim, and D Grădinariu, and V Papa, and A Manolescu, and A Bădescu

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008297 Male Males
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D002995 Clofibric Acid An antilipemic agent that is the biologically active metabolite of CLOFIBRATE. Clofibrinic Acid,2-(4-Chlorophenoxy)-2-methylpropionic Acid,NSC-1149,p-Chlorophenoxyisobutyrate,p-Chlorophenoxyisobutyric Acid,NSC 1149,NSC1149
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005260 Female Females

Related Publications

G Dănilă, and M Nechifor, and M Filip, and I Păduraru, and C Ifrim, and D Grădinariu, and V Papa, and A Manolescu, and A Bădescu
[Hypolipemic effect of amino acid derivatives of clofibric acid].
January 1985, Acta poloniae pharmaceutica,
G Dănilă, and M Nechifor, and M Filip, and I Păduraru, and C Ifrim, and D Grădinariu, and V Papa, and A Manolescu, and A Bădescu
[Serum gas chromatographic determination of hypolipemic agents derived from clofibric acid].
January 1976, Therapie,
G Dănilă, and M Nechifor, and M Filip, and I Păduraru, and C Ifrim, and D Grădinariu, and V Papa, and A Manolescu, and A Bădescu
The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid.
September 1992, Biochimica et biophysica acta,
G Dănilă, and M Nechifor, and M Filip, and I Păduraru, and C Ifrim, and D Grădinariu, and V Papa, and A Manolescu, and A Bădescu
Pharmacokinetics and bioavailability of simfibrate a new clofibric acid derivative.
January 1976, Current therapeutic research, clinical and experimental,
G Dănilă, and M Nechifor, and M Filip, and I Păduraru, and C Ifrim, and D Grădinariu, and V Papa, and A Manolescu, and A Bădescu
[Research regarding the action of a derivative of the clofibric acid series on lipid metabolism].
January 1987, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
G Dănilă, and M Nechifor, and M Filip, and I Păduraru, and C Ifrim, and D Grădinariu, and V Papa, and A Manolescu, and A Bădescu
[The use of acetylsalicylic acid as a platelet antiaggregant].
August 1992, Arquivos brasileiros de cardiologia,
G Dănilă, and M Nechifor, and M Filip, and I Păduraru, and C Ifrim, and D Grădinariu, and V Papa, and A Manolescu, and A Bădescu
Potent platelet antiaggregant action of an antiarrhythmic peptide (AAP).
February 1986, Journal of pharmacobio-dynamics,
G Dănilă, and M Nechifor, and M Filip, and I Păduraru, and C Ifrim, and D Grădinariu, and V Papa, and A Manolescu, and A Bădescu
[Pharmacokinetic study in man of hypolipemic agents derived from clofibric acid after single and repeated administration].
January 1976, Therapie,
G Dănilă, and M Nechifor, and M Filip, and I Păduraru, and C Ifrim, and D Grădinariu, and V Papa, and A Manolescu, and A Bădescu
Clinical research into the hypolipemic and platelet antiaggregant activity of plafibride, Carried out in double-blind conditions and in comparison with clofibrate.
January 1981, Arzneimittel-Forschung,
G Dănilă, and M Nechifor, and M Filip, and I Păduraru, and C Ifrim, and D Grădinariu, and V Papa, and A Manolescu, and A Bădescu
[Platelet aggregation and antiaggregant drugs].
November 1982, Recenti progressi in medicina,
Copied contents to your clipboard!